key: cord-0897442-x3gsc1hv
authors: Chen, Chen; Li, Jizhou; Di, Lin; Jing, Qiuyu; Du, Pengcheng; Song, Chuan; Li, Jiarui; Li, Qiong; Cao, Yunlong; Xie, X. Sunney; Wu, Angela R.; Zeng, Hui; Huang, Yanyi; Wang, Jianbin
title: MINERVA: A facile strategy for SARS-CoV-2 whole genome deep sequencing of clinical samples
date: 2020-11-20
journal: Mol Cell
DOI: 10.1016/j.molcel.2020.11.030
sha: 790d55434e0ded5afbe37b23eb8e5cf7cd57d742
doc_id: 897442
cord_uid: x3gsc1hv

Analyzing the genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from clinical samples is crucial for the understanding of viral spread and viral evolution, as well as for vaccine development. Existing RNA sequencing methods are demanding on user technique and time, and thus not ideal for time-sensitive clinical samples; these methods are also not optimized for high performance on viral genomes. We have developed a facile, practical, and robust approach for metagenomic and deep viral sequencing from clinical samples. We demonstrate the utility of our approach on pharyngeal, sputum and stool samples collected from COVID-19 patients, successfully obtaining both whole metatranscriptomes and complete high-depth high-coverage SARS-CoV-2 genomes from these clinical samples, with high yield and robustness. With a shortened hands-on time from sample to virus-enriched sequencing-ready library, this rapid, versatile, and clinic-friendly approach will facilitate molecular epidemiology studies during outbreaks, both current and future.

Analyzing the genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV- samples; these methods are also not optimized for high performance on viral genomes. 37 We have developed a facile, practical, and robust approach for metagenomic and deep 38 viral sequencing from clinical samples. We demonstrate the utility of our approach on 39 pharyngeal, sputum and stool samples collected from COVID-19 patients, successfully 40 obtaining both whole metatranscriptomes and complete high-depth high-coverage 41 SARS-CoV-2 genomes from these clinical samples, with high yield and robustness.

Introduction 46 As of Nov 4, 2020, the ongoing COVID-19 viral pandemic has affected more than46 million people in over 200 countries and territories around the world, and has claimed Currently, the most comprehensive strategy is the combination of metatranscriptomics 77 profiling with post-library SARS-CoV-2 target enrichment . However, 78 in most conventional RNA-seq methods, the double-strand DNA ligation (dsDL) portion 79 of the protocol is usually the most demanding on hands-on time and user technique (Di 80 et al., 2020). When superimposed on the target enrichment process, these labor- experiments. The whole procedure from nucleic acid to metagenomic sequencing-ready 139 library, including wait time, takes 5.5 hours (Fig. S1A) . April 2020, presenting different symptom severity ( Fig. 2A and Tables S1 and S2). 153 Some patients were re-sampled longitudinally to investigate temporal and intra-host 154 viral heterogeneity. In addition to the patient samples, we also included different sample 155 types from eight healthy individuals as well as non-template control (NTC) samples. We 156 first tested the effect of sample input volume on MINERVA results. Using just 2.7-ul of heterogeneity as measured by Species richness and Shannon index was correlated 176 between the two ( Fig. S2B and S2C) . To ensure the accuracy of our metagenomic 177 computational pipeline, we employed both metagenomics and metagenome assembly 178 strategies to profile microbial compositions of different types of samples. For assembly, 179 we combined reads from samples of the same type together for co-assembly, thus 180 obtaining contigs for each sample type. After taxonomy assignment at contigs level, 181 reads from each individual sample were mapped back to the co-assembled contigs to 182 obtain the microbial composition of each individual sample. Overall, we found the 183 results of microbial compositions profiled from metagenomic and assembly strategies to 184 be comparable (Fig. S2D-F (Fig. 3B) . Based on this result, we segmented pharyngeal 206 samples into Healthy, Non-critical (including "Mild", "Moderate" and "Severe" samples) 207 and Critical groups. Decreased alpha diversities were observed in patient samples.

Lower Shannon index was observed in Non-critical group compared to healthy controls.

The most strongly and significantly decreased alpha diversity was observed in Critical 210 samples, in terms of both species richness and Shannon index (Fig. 3C) Veillonella were associated with critical disease (Fig. 3D, left panel) . Among these, 220 Streptococcus and Rothia were highly enriched in non-critical patient group, Prevotella 221 and Veillonella were abundant and prevalent in both healthy and non-critical groups.

Acinetobacter and Acidovorax were enriched in both healthy and critical groups while 223 Halomonas was only highly enriched in critical samples (Fig. 3D, right panel) . Although 224 some of these microbes were also detected in one of the NTCs, their abundance was 225 quite low compared to patient samples (Fig S3I) . Also, they are known to be abundant were not separated by disease severity (Fig. S3D) . Shannon index is lower in patient 233 samples compared to healthy controls, while no significant difference of species 234 richness was observed (Fig. S3E) . GEE analysisfound that Streptococcus, Rothia and 235 Veillonella were associated with disease ( Fig. S3F) : Streptococcus and Rothia were 236 enriched in patient group, while Veillonella was enriched and more prevalent in healthy 237 samples. For stool samples, no difference was observed between patient samples and 238 healthy controls in term of PCoA on Bray-Curtis distance (Fig. S3G) and alpha 239 diversities, including both species richness and Shannon index (Fig. S3H) . These 240 results were also consistent with PERMANOVA analysis (Fig. 3A) .

By surveying the metagenomic landscape of these samples, we also observed several 243 patient samples with exceptionally high abundance of additional known pathogens, 244 including Candida albicans, Staphylococcus aureus, Corynebacterium jeikeium, 245 Corynebacterium striatum and Klebsiella aerogenes (Fig. 4A, left panels) . To validate 246 these results, we directly mapped the reads to the individual genome of each species 247 and assessed the genome coverage of each sample, normalized by sequencing depth 248 (Fig. 4A, right panel) . Generally, the metagenomics results were consistent with the 249 direct-mapping results, and were also consistent with assembly results (Fig. S4) . The 250 occurrence rate of these species with high abundance identified by both metagenomics 251 and direct-mapping is also associated with disease severity (Fig. 4B) . For severe viral 252 pneumonia, co-infections can greatly affect patient outcomes; one recent study showed 253 that 50% of patients with COVID-19 who have died in this pandemic had secondary sequencing dsDL libraries to two orders of magnitude more depth (Fig. S2A) . Only samples with high abundance of these pathogens identified by both metagenomics 509 analysis and direct mapping were considered here and were also labeled in panel E.

The occurrence rate was associated with disease severity. Centrifuge was used to assign taxonomies to contigs using the database mentioned corresponding samples and then multiply a scaling factor of 1,000,000 for comparisons. 694 We calculated the relative abundance of taxa as the ratio of reads assigned to that taxa 695 for the metagenomic strategy, then compared it with the ratio of reads mapped to 696 contigs which were assigned as that taxa for the metagenome assembly strategy. 0  4000  8000  12000  16000  20000  24000  28000  29903   snp   Indel   C241T   T11458A   C3037T  C14408T   A23403G   T28144C   T28688C  A24950T  G26144T   C8782T 

Clinical characteristics 744 of the recovered COVID-19 patients with re-detectable positive RNA test. medRxiv

Presumed Asymptomatic Carrier 746 Transmission of COVID-19

BBMap: A Fast, Accurate, Splice-Aware Aligner

SARS-CoV-749 2-Positive Sputum and Feces After Conversion of Pharyngeal Samples in Patients With COVID-19

Co-infections: potentially lethal and unexplored in COVID-752 19

Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults: An Observational Cohort Study

Medicine (Baltimore) 94, e2332

Prevalence of Escherichia coli carriage in the 757 oropharynx of ambulatory children and adults with and without upper respiratory symptoms

A Genomic Survey of SARS-CoV-2 Reveals Multiple Introductions into Northern California without a 761

RNA sequencing by direct 763 tagmentation of RNA/DNA hybrids

STAR: ultrafast universal RNA-seq aligner

Covid-19 -Navigating the Uncharted

Gut Microbiota in Patients with COVID-19 or H1N1 Influenza

Spread of SARS-CoV-2 in the Icelandic Population

Temporal 775 dynamics in viral shedding and transmissibility of COVID-19

Structure, function and diversity of the healthy human microbiome

and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

BEDTools: a flexible suite of utilities for comparing genomic features

Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support 800 COVID-19 antimicrobial prescribing

Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study

Bacterial and viral co-infections complicating severe influenza: Incidence 806 and impact among 507 U.S. patients, 2013-14

Genomic 808 Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients With Coronavirus Disease

Detection of SARS-CoV-2 in Different Types of 811 Clinical Specimens

WHO Coronavirus Disease (COVID-19) Dashboard

Virological assessment of hospitalized patients with COVID-2019

A new 816 coronavirus associated with human respiratory disease in China

Multiple approaches for 818 massively parallel sequencing of SARS-CoV-2 genomes directly from clinical samples

Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore

Defining the healthy "core microbiome" of oral 823 microbial communities

Clinical course and 825 risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

A 828 pneumonia outbreak associated with a new coronavirus of probable bat origin

Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization

 Y2  Y6  154  077 072 078   C241T  C313T  C635T  C884T  A901C  C1059T  C1302T  G1397A  T1557C  T1798G  G2229A  C2416T  G2962T  C3037T  C3117T  A3305G  3333 del TTG  C3768T  3951 del ATA  C5183T  G5230T  G6819T  C8481T  G8653T  C8727T  C8782T  T9477A  C9967T  C10747T  C11001T  C11020T  11074 ins T  11075 del T  11083 T25189C  G25217T  G25331T  T25519C  G25563T  G25979T  G26144T  A26528T  A26530G  A26579T  T26729C  T26975G  C27208T  G27226A  T27384C  C27476T  C27688A  G28027A  G28077C  28090 del GTTCTA  T28144C  C28253T  A28305C  C28657T  T28688C  A28765G  G28812T  C28826T  C28854T  C28863T  T28867C  G28881A  G28882A  G28883C  C28915T  29378 del A  G29473A  G29527A  G29648T  G29734C  G29742T  C29743T  C29774T  025